Shionogi & Co., Ltd. (4507.T)
JPY 2178.5
(0.51%)
JPY 2178.5
(0.51%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 11.62 Billion JPY | 23.47% |
| 2022 | 9.41 Billion JPY | 41.01% |
| 2021 | 6.67 Billion JPY | -16.44% |
| 2020 | 7.98 Billion JPY | -2.02% |
| 2019 | 8.15 Billion JPY | 786.09% |
| 2018 | 920 Million JPY | -96.77% |
| 2017 | 28.49 Billion JPY | -5.2% |
| 2016 | 30.05 Billion JPY | -0.07% |
| 2015 | 30.07 Billion JPY | -0.19% |
| 2014 | 30.13 Billion JPY | 0.33% |
| 2013 | 30.03 Billion JPY | -56.49% |
| 2012 | 69.02 Billion JPY | -25.78% |
| 2011 | 93 Billion JPY | -13.08% |
| 2010 | 107 Billion JPY | -11.57% |
| 2009 | 121 Billion JPY | 5.22% |
| 2008 | 115 Billion JPY | 0.0% |
| 2007 | - JPY | -100.0% |
| 2006 | 2.06 Billion JPY | -62.9% |
| 2005 | 5.56 Billion JPY | -79.19% |
| 2004 | 26.76 Billion JPY | 26.17% |
| 2003 | 21.21 Billion JPY | -26.18% |
| 2002 | 28.73 Billion JPY | -28.19% |
| 2001 | 40.01 Billion JPY | 0.23% |
| 2000 | 39.92 Billion JPY | 1.54% |
| 1999 | 39.31 Billion JPY | 11.65% |
| 1998 | 35.21 Billion JPY | 12.33% |
| 1997 | 31.34 Billion JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 3.28 Billion JPY | -72.64% |
| 2024 Q1 | 12.02 Billion JPY | 3.46% |
| 2023 Q3 | 9.84 Billion JPY | 4.31% |
| 2023 Q1 | 9.55 Billion JPY | 1.49% |
| 2023 Q2 | 9.43 Billion JPY | -1.19% |
| 2023 FY | 11.62 Billion JPY | 23.47% |
| 2023 Q4 | 11.62 Billion JPY | 18.04% |
| 2022 Q4 | 9.41 Billion JPY | 8.71% |
| 2022 FY | 9.41 Billion JPY | 41.01% |
| 2022 Q1 | 6.64 Billion JPY | -0.42% |
| 2022 Q2 | 6.81 Billion JPY | 2.54% |
| 2022 Q3 | 8.65 Billion JPY | 27.03% |
| 2021 Q1 | 7.74 Billion JPY | -2.98% |
| 2021 FY | 6.67 Billion JPY | -16.44% |
| 2021 Q4 | 6.67 Billion JPY | -5.79% |
| 2021 Q3 | 7.08 Billion JPY | -4.7% |
| 2021 Q2 | 7.43 Billion JPY | -4.08% |
| 2020 FY | 7.98 Billion JPY | -2.02% |
| 2020 Q1 | 8.02 Billion JPY | -1.55% |
| 2020 Q3 | 7.42 Billion JPY | -3.91% |
| 2020 Q4 | 7.98 Billion JPY | 7.63% |
| 2020 Q2 | 7.72 Billion JPY | -3.78% |
| 2019 Q2 | 740 Million JPY | -17.78% |
| 2019 Q1 | 900 Million JPY | -2.17% |
| 2019 Q4 | 8.15 Billion JPY | 0.0% |
| 2019 FY | 8.15 Billion JPY | 786.09% |
| 2019 Q3 | - JPY | -100.0% |
| 2018 FY | 920 Million JPY | -96.77% |
| 2018 Q2 | 13.17 Billion JPY | -53.76% |
| 2018 Q4 | 920 Million JPY | -87.49% |
| 2018 Q3 | 7.35 Billion JPY | -44.19% |
| 2018 Q1 | 28.48 Billion JPY | -0.02% |
| 2017 Q1 | 30.04 Billion JPY | -0.02% |
| 2017 FY | 28.49 Billion JPY | -5.2% |
| 2017 Q4 | 28.49 Billion JPY | -1.95% |
| 2017 Q3 | 29.05 Billion JPY | -2.93% |
| 2017 Q2 | 29.93 Billion JPY | -0.39% |
| 2016 Q3 | 30.05 Billion JPY | -0.02% |
| 2016 Q4 | 30.05 Billion JPY | -0.02% |
| 2016 Q2 | 30.06 Billion JPY | -0.02% |
| 2016 Q1 | 30.06 Billion JPY | -0.02% |
| 2016 FY | 30.05 Billion JPY | -0.07% |
| 2015 Q3 | 30.07 Billion JPY | -0.02% |
| 2015 Q1 | 30.08 Billion JPY | -0.14% |
| 2015 Q2 | 30.08 Billion JPY | -0.02% |
| 2015 Q4 | 30.07 Billion JPY | -0.02% |
| 2015 FY | 30.07 Billion JPY | -0.19% |
| 2014 Q1 | 10.03 Billion JPY | -66.59% |
| 2014 Q3 | 30.13 Billion JPY | 200.38% |
| 2014 Q2 | 10.03 Billion JPY | -0.01% |
| 2014 Q4 | 30.13 Billion JPY | -0.01% |
| 2014 FY | 30.13 Billion JPY | 0.33% |
| 2013 Q2 | 62.03 Billion JPY | -9.48% |
| 2013 FY | 30.03 Billion JPY | -56.49% |
| 2013 Q4 | 30.03 Billion JPY | -51.19% |
| 2013 Q3 | 61.53 Billion JPY | -0.81% |
| 2013 Q1 | 68.53 Billion JPY | -0.72% |
| 2012 Q4 | 69.02 Billion JPY | -8.6% |
| 2012 FY | 69.02 Billion JPY | -25.78% |
| 2012 Q1 | 82.52 Billion JPY | -11.26% |
| 2012 Q2 | 76.02 Billion JPY | -7.88% |
| 2012 Q3 | 75.52 Billion JPY | -0.66% |
| 2011 Q3 | 99.5 Billion JPY | -0.5% |
| 2011 Q1 | 106.5 Billion JPY | -0.47% |
| 2011 Q4 | 93 Billion JPY | -6.53% |
| 2011 FY | 93 Billion JPY | -13.08% |
| 2011 Q2 | 100 Billion JPY | -6.1% |
| 2010 Q2 | 114 Billion JPY | -5.39% |
| 2010 Q3 | 113.5 Billion JPY | -0.44% |
| 2010 Q4 | 107 Billion JPY | -5.73% |
| 2010 Q1 | 120.5 Billion JPY | -0.41% |
| 2010 FY | 107 Billion JPY | -11.57% |
| 2009 Q3 | 127.83 Billion JPY | -0.39% |
| 2009 FY | 121 Billion JPY | 5.22% |
| 2009 Q4 | 121 Billion JPY | -5.35% |
| 2009 Q2 | 128.33 Billion JPY | 0.0% |
| 2008 Q4 | 115 Billion JPY | 0.0% |
| 2008 FY | 115 Billion JPY | 0.0% |
| 2007 FY | - JPY | -100.0% |
| 2006 FY | 2.06 Billion JPY | -62.9% |
| 2005 FY | 5.56 Billion JPY | -79.19% |
| 2004 FY | 26.76 Billion JPY | 26.17% |
| 2003 FY | 21.21 Billion JPY | -26.18% |
| 2002 FY | 28.73 Billion JPY | -28.19% |
| 2001 FY | 40.01 Billion JPY | 0.23% |
| 2000 FY | 39.92 Billion JPY | 1.54% |
| 1999 FY | 39.31 Billion JPY | 11.65% |
| 1998 FY | 35.21 Billion JPY | 12.33% |
| 1997 FY | 31.34 Billion JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 16.89 Billion JPY | 31.206% |
| Takeda Pharmaceutical Company Limited | 4843.75 Billion JPY | 99.76% |
| Sumitomo Pharma Co., Ltd. | 418.88 Billion JPY | 97.226% |
| Wakamoto Pharmaceutical Co.,Ltd. | 100.52 Million JPY | -11458.854% |
| Nippon Shinyaku Co., Ltd. | 2.87 Billion JPY | -304.596% |
| Kaken Pharmaceutical Co., Ltd. | 3.85 Billion JPY | -201.818% |
| Eisai Co., Ltd. | 206.74 Billion JPY | 94.38% |
| Morishita Jintan Co., Ltd. | 425 Million JPY | -2634.118% |
| Hisamitsu Pharmaceutical Co., Inc. | 2.1 Billion JPY | -453.333% |
| Mochida Pharmaceutical Co., Ltd. | 369 Million JPY | -3049.051% |
| Fuso Pharmaceutical Industries,Ltd. | 12.72 Billion JPY | 8.662% |
| Nippon Chemiphar Co., Ltd. | 16.98 Billion JPY | 31.571% |
| Tsumura & Co. | 79.69 Billion JPY | 85.418% |
| Kissei Pharmaceutical Co., Ltd. | 1.72 Billion JPY | -572.843% |
| Torii Pharmaceutical Co., Ltd. | 244 Million JPY | -4662.295% |
| Towa Pharmaceutical Co., Ltd. | 202.35 Billion JPY | 94.258% |
| Fuji Pharma Co., Ltd. | 28.94 Billion JPY | 59.859% |
| Zeria Pharmaceutical Co., Ltd. | 47.58 Billion JPY | 75.581% |
| KYORIN Holdings, Inc. | 20.94 Billion JPY | 44.524% |
| Taiko Pharmaceutical Co.,Ltd. | 3.8 Billion JPY | -205.067% |
| Daito Pharmaceutical Co.,Ltd. | 8.71 Billion JPY | -33.272% |
| SymBio Pharmaceuticals Limited | - JPY | -Infinity% |
| MedRx Co., Ltd | - JPY | -Infinity% |
| Mizuho Medy Co.,Ltd. | - JPY | -Infinity% |
| Solasia Pharma K.K. | 60 Million JPY | -19266.667% |
| Modalis Therapeutics Corporation | 412.5 Million JPY | -2716.97% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 9.48 Billion JPY | -22.509% |
| Sawai Group Holdings Co., Ltd. | 82.89 Billion JPY | 85.981% |
| Cyfuse Biomedical K.K. | 913 Million JPY | -1172.727% |
| Toho Holdings Co., Ltd. | 30.24 Billion JPY | 61.579% |
| Koa Shoji Holdings Co.,Ltd. | 2.82 Billion JPY | -311.286% |